Metformin in Combination With Dipeptidyl Peptidase-4 Inhibitors or Sulfonylureas in The Treatment of Type 2 Diabetes- Clinical And Economic Impact

Nov 1, 2014, 00:00 AM
10.1016/j.jval.2014.08.669
https://www.valueinhealthjournal.com/article/S1098-3015(14)02599-6/fulltext
Section Title : Disease-Specific Studies
Section Order : 90
First Page : A339
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)02599-6&doi=10.1016/j.jval.2014.08.669
HEOR Topics :
Tags :
Regions :